Hi-Tech Pharmacal Co. (HITK) Misses Q4 EPS by 5c
Tweet Send to a FriendGet Alerts HITK Hot Sheet
Price: $33.70 -1.98%
Financial Fact:
Weighted average common shares outstanding-basic: 13.41M
Today's EPS Names:
ANF, DXLG, FL, More
Financial Fact:
Weighted average common shares outstanding-basic: 13.41M
Today's EPS Names:
ANF, DXLG, FL, More
Trade HITK Now!
Hi-Tech Pharmacal Co. (NASDAQ: HITK) reported Q4 EPS of $0.73, $0.05 worse than the analyst estimate of $0.78. Revenue for the quarter came in at $61.3 million versus the consensus estimate of $57.94 million.
For earnings history and earnings-related data on Hi-Tech Pharmacal Co. (HITK) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For earnings history and earnings-related data on Hi-Tech Pharmacal Co. (HITK) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Abercrombie & Fitch Co. (ANF) Misses Q1 EPS by 4c; Guides FY Below Views
- Nordson Corp (NDSN) Reports In-Line Q2 EPS, Q3 Guidance Falls Short
- UPDATE: Sears Holding Corp. (SHLD) Reports Q1 Loss of $1.29
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
